Author
Listed:
- Eriko Tanaka
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Graduate School of Medicine, Tokyo Medical and Dental University)
- Katsuhiko Asanuma
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Medical Innovation Center, Laboratory for Kidney Research(TMK project), Kyoto University Graduate School of Medicine)
- Eunhee Kim
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Yu Sasaki
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Juan Alejandro Oliva Trejo
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Takuto Seki
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Kanae Nonaka
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Rin Asao
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Yoshiko Nagai-Hosoe
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Miyuki Akiba-Takagi
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Teruo Hidaka
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
- Masatoshi Takagi
(Graduate School of Medicine, Tokyo Medical and Dental University)
- Akemi Koyanagi
(Biomedical Reseach Center, Juntendo University Graduate School of Medicine)
- Shuki Mizutani
(Graduate School of Medicine, Tokyo Medical and Dental University)
- Hideo Yagita
(Biomedical Reseach Center, Juntendo University Graduate School of Medicine
Juntendo University School of Medicine)
- Yasuhiko Tomino
(Juntendo University Faculty of Medicine, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan)
Abstract
Activation of Notch1 and Notch2 has been recently implicated in human glomerular diseases. Here we show that Notch2 prevents podocyte loss and nephrosis. Administration of a Notch2 agonistic monoclonal antibody ameliorates proteinuria and glomerulosclerosis in a mouse model of nephrosis and focal segmental glomerulosclerosis. In vitro, the specific knockdown of Notch2 increases apoptosis in damaged podocytes, while Notch2 agonistic antibodies enhance activation of Akt and protect damaged podocytes from apoptosis. Treatment with triciribine, an inhibitor of Akt pathway, abolishes the protective effect of the Notch2 agonistic antibody. We find a positive linear correlation between the number of podocytes expressing activated Notch2 and the number of residual podocytes in human nephrotic specimens. Hence, specific activation of Notch2 rescues damaged podocytes and activating Notch2 may represent a novel clinical strategy for the amelioration of nephrosis and glomerulosclerosis.
Suggested Citation
Eriko Tanaka & Katsuhiko Asanuma & Eunhee Kim & Yu Sasaki & Juan Alejandro Oliva Trejo & Takuto Seki & Kanae Nonaka & Rin Asao & Yoshiko Nagai-Hosoe & Miyuki Akiba-Takagi & Teruo Hidaka & Masatoshi Ta, 2014.
"Notch2 activation ameliorates nephrosis,"
Nature Communications, Nature, vol. 5(1), pages 1-10, May.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4296
DOI: 10.1038/ncomms4296
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4296. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.